Skip to main content

March 2022

 

 

academics

 

Clinical research courses

Novartis looking for Senior Scientific Writer | Ph.D, M.Pharm, M.Sc apply

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Senior Scientific Writer II

Walk in interview for B.Pharm in Production Department at ANNORA Pharma

Established in 2016, ANNORA Pharma is committed to provide medicines with highest quality, safety and efficacy that meets the needs of the customers with applicable statutory and regulatory requirements.  Spread over in thirty-five acres land, our manufacturing facility close to the city of Hyderabad, India specializes in manufacturing of Tablets, Capsules, Pellets, Liquid Orals, Suppositories and Dry Powder Syrups catering to a diverse therapeutic range.

Rice Ferment Filtrate in Cosmetics

Vinay Kumar SinghAbout Author
Vinay Kumar Singh.  
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru

Aleor Dermaceuticals Limited receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP

Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 U/g/0.1%, of Taro Pharmaceuticals U.S.A. Inc. Nystatin and Triamcinolone

Rutgers Researchers Harness AI and Robotics to Treat Spinal Cord Injuries

By employing artificial intelligence (AI) and robotics to formulate therapeutic proteins, a team led by Rutgers researchers has successfully stabilized an enzyme able to degrade scar tissue resulting from spinal cord injuries and promote tissue regeneration.

Novel Antiviral Drug Combinations Demonstrate COVID-19 Therapeutic Potential

Researchers from Columbia Engineering, Fiocruz’s Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

Lipid profile can predict risk of diabetes and CVD decades before incidence

Recent large population cohort analysis demonstrated that a subset of individuals at high risk for developing type 2 diabetes or cardiovascular diseases can be predicted years before disease incidence. The study is published in Plos Biology.

2nd Annual Pharma GMP, GCP & Quality Management 2022

Following its successful Launch, Eminence Business Media is hosting the 2nd Annual Pharma GMP, GCP & Quality Management 2022 in Mumbai. The program offers unparalleled business, research opportunities, networking platforms, and access to new trends in Indian Pharma Industry.

For this constantly evolving industry, this summit helps identify opportunities for overall growth in aspects of Quality Management, Good Manufacturing Practices, Good Clinical Practices, as well as Risk Management.

Recruitment for Pharmacy Graduates (37 posts) at KAPL - Government of India Enterprise

Karnataka Antibiotics and Pharmaceuticals Limited, KAPL Bengaluru is a Government of India Enterprise. Karnataka Antibiotics and Pharmaceuticals Limited is a Joint Sector Company of Government of India with shareholding from Government of Karnataka through Karnataka State Industrial Infrastructure Development Corporation KSIIDC. From a modest beginning in 1984, KAPL has grown exponentially in the areas of manufacturing and marketing of various life saving and essential drugs.